Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Sectoral/ Thematic median (252 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 17 Jan 2008 – 20 Aug 2026. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one. Nifty 500 history starts 25 Jul 2016, so that benchmark is not plotted over this window — pick a shorter range to see it.
View as table
| Date | Franklin Asian Equity Fund |
|---|---|
| 17 Jan 2008 | ₹100.00 |
| 05 Aug 2009 | ₹102.88 |
| 22 Feb 2011 | ₹113.26 |
| 10 Sep 2012 | ₹126.29 |
| 29 Mar 2014 | ₹148.57 |
| 16 Oct 2015 | ₹161.79 |
| 04 May 2017 | ₹196.65 |
| 21 Nov 2018 | ₹204.87 |
| 09 Jun 2020 | ₹254.29 |
| 27 Dec 2021 | ₹307.28 |
| 15 Jul 2023 | ₹279.22 |
| 31 Jan 2025 | ₹298.31 |
| 20 Aug 2026 | ₹480.87 |
| Metric | Franklin Templeton · Regular NAV ₹45.65 Very High risk ★★★☆☆ | Category median Sectoral/ Thematic · 252 funds |
|---|---|---|
| +43.65% | +5.83% | |
| +23.11% | +15.63% | |
| +9.50% | +13.23% | |
| +9.99% | +13.85% | |
| +8.81% | +12.26% | |
| +19.67% | — | |
| +8.33% | +15.60% | |
| +8.24% | +14.52% | |
| +8.60% | +13.74% | |
| Risk | ||
| 16.73% | 15.62% | |
| 0.99 | 0.43 | |
| 1.42 | 0.59 | |
| -42.78% | -23.65% | |
| Nifty 500 | — | |
| +12.27% | +3.42% | |
| 0.59 | 0.95 | |
| 76.6% | 105.9% | |
| -5.6% | 93.6% | |
| 2.57% | 2.39% | |
| ₹720.84Cr | ₹1,161Cr | |
| 1.00% | — | |
| None | — | |
| ₹500 | — | |
| ₹5.00K | — | |
| 7% | 45% | |
| Sandeep Manam · 4.8y | — | |
| 17 Jan 2008 | — | |
| 29 | — | |
| 20.1% | — | |
| 8.8% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.